Aurobindo Pharma Limited (BOM:524804)
India flag India · Delayed Price · Currency is INR
1,041.65
-23.70 (-2.22%)
At close: Aug 8, 2025

Aurobindo Pharma Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 20212017 - 2021
Period Ending
Jun '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2017 - 2021
Net Income
-34,85931,73019,27526,48253,348
Upgrade
Depreciation & Amortization
-16,49414,39411,96210,83310,554
Upgrade
Other Amortization
--525.2413.1432.4-
Upgrade
Loss (Gain) From Sale of Assets
-89.4-234.9-132.31,558-31,084
Upgrade
Asset Writedown & Restructuring Costs
-114.2623.7309.9-396.34,349
Upgrade
Loss (Gain) From Sale of Investments
--367-1--264.3-
Upgrade
Loss (Gain) on Equity Investments
-316.9171.5116.7312.5553.6
Upgrade
Provision & Write-off of Bad Debts
-188232.8524.5-61.1-291.2
Upgrade
Other Operating Activities
--3.5-6,3452,348-4,3096,527
Upgrade
Change in Accounts Receivable
--8,621-2,642-4,321-4,1087,440
Upgrade
Change in Inventory
--7,355-13,037-9,26714,975-16,217
Upgrade
Change in Accounts Payable
--3,1095,8287,0771,1071,265
Upgrade
Change in Other Net Operating Assets
-6,640-6,900-4,4383,605-3,155
Upgrade
Operating Cash Flow
-39,24624,34523,86850,16533,291
Upgrade
Operating Cash Flow Growth
-61.21%2.00%-52.42%50.69%-24.02%
Upgrade
Capital Expenditures
--19,679-27,803-24,038-20,529-14,379
Upgrade
Sale of Property, Plant & Equipment
-28.4602.8110.93,809481.7
Upgrade
Cash Acquisitions
--113.9--1,970-5,814-2,742
Upgrade
Divestitures
----43.231,739
Upgrade
Sale (Purchase) of Intangibles
--5,517-7,812-3,166-6,517-4,359
Upgrade
Investment in Securities
-881.61,5354,428-3,361-4,674
Upgrade
Other Investing Activities
-5,641-9,082-15,142252.6-79.6
Upgrade
Investing Cash Flow
--18,758-42,560-39,778-32,1165,987
Upgrade
Short-Term Debt Issued
-20,611-20,697--
Upgrade
Long-Term Debt Issued
-6,61415,6323,936827.31,770
Upgrade
Total Debt Issued
-27,22615,63224,633827.31,770
Upgrade
Short-Term Debt Repaid
---847.6--26,367-6,678
Upgrade
Long-Term Debt Repaid
--12,287-1,638-981.2-1,331-5,904
Upgrade
Total Debt Repaid
--12,287-2,485-981.2-27,698-12,583
Upgrade
Net Debt Issued (Repaid)
-14,93913,14723,651-26,871-10,813
Upgrade
Repurchase of Common Stock
--9,302----
Upgrade
Common Dividends Paid
--10.4-2,636-4,395-2,637-2,343
Upgrade
Other Financing Activities
--4,428-2,507-1,112-185-493.5
Upgrade
Financing Cash Flow
-1,1988,00418,144-29,693-13,649
Upgrade
Foreign Exchange Rate Adjustments
-91141.7-0.62-21.2
Upgrade
Miscellaneous Cash Flow Adjustments
-6.6-64.1-32.5224.1
Upgrade
Net Cash Flow
-21,784-10,0682,298-11,67425,831
Upgrade
Free Cash Flow
-19,568-3,458-170.529,63618,911
Upgrade
Free Cash Flow Growth
----56.71%-36.93%
Upgrade
Free Cash Flow Margin
-6.17%-1.19%-0.07%12.63%7.63%
Upgrade
Free Cash Flow Per Share
-33.57-5.90-0.2950.5832.27
Upgrade
Cash Interest Paid
-4,2032,5071,112185493.5
Upgrade
Cash Income Tax Paid
-17,31417,6667,17212,58212,853
Upgrade
Levered Free Cash Flow
-11,753-12,590-4,80312,12913,662
Upgrade
Unlevered Free Cash Flow
-14,611-10,914-3,99712,35914,035
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.